GADD45A, a potent inhibitor of the c-Jun N-terminal kinase (JNK) cascade and NFKBIA, inhibits transcription factors associated with tumor growth [71-74] and was up-regulated by doxorubicin in 12 probes. Here, NFKBIA is linked to neoplasm.